Latest Commercial Growth News

Page 1 of 5
Papyrus Australia has taken a significant step towards commercialisation by signing a $4.2 million supply contract with TBS Mining Solutions for its biodegradable Collar Keeper® products, while advancing its Adelaide R&D facility.
Victor Sage
Victor Sage
30 Dec 2025
Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.
Ada Torres
Ada Torres
4 Dec 2025
6K Additive has landed a landmark US$27.4 million loan from the US Export-Import Bank, partnering with the Department of War to fund a major expansion in Pennsylvania that will quintuple powder production capacity and create over 50 new jobs.
Victor Sage
Victor Sage
4 Dec 2025
Titomic Limited has successfully completed a hot fire test on a solid rocket motor thrust chamber made with its Titomic Kinetic Fusion cold spray technology, marking a significant milestone in aerospace additive manufacturing.
Victor Sage
Victor Sage
2 Dec 2025
Oneview Healthcare reported robust commercial growth in 2025, driven by new US client wins and the launch of its AI-powered care assistant, Ovie. The company enters 2026 with a confident outlook focused on expanding its US footprint and advancing digital health innovation.
Victor Sage
Victor Sage
2 Dec 2025
Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.
Ada Torres
Ada Torres
26 Nov 2025
First Graphene Limited has raised A$3.5 million through a share placement to accelerate the commercial adoption of its PureGRAPH graphene products and support ongoing operations.
Maxwell Dee
Maxwell Dee
11 Nov 2025
InteliCare successfully completed its largest aged care pilot at mecwacare’s Trescowthick Centre and secured $2 million in funding, while navigating a key leadership transition.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.
Victor Sage
Victor Sage
31 Oct 2025
Alexium International Group reported a 26% rise in Q1 FY26 sales driven by new business wins and expanded foam bedding applications, while navigating tighter funding conditions.
Victor Sage
Victor Sage
31 Oct 2025
Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.
Victor Sage
Victor Sage
28 Oct 2025
Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.
Victor Sage
Victor Sage
20 Oct 2025